{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:46:06Z","timestamp":1774525566253,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cca.2013.07.018","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T15:47:05Z","timestamp":1375372025000},"page":"125-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Novel mutations in myopathic form of carnitine palmitoyltransferase II deficiency in a Chinese patient"],"prefix":"10.1016","volume":"425","author":[{"given":"Sun Young","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tak-Shing","family":"Siu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-wan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.07.018_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejim.2007.04.025","article-title":"Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency","volume":"19","author":"Deutsch","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cca.2013.07.018_bb0010","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.nmd.2007.05.002","article-title":"Identification of the infant-type R631C mutation in patients with the benign muscular form of CPT2 deficiency","volume":"17","author":"Musumeci","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.cca.2013.07.018_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","article-title":"Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency","volume":"89","author":"Isackson","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.07.018_bb0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/mgme.1999.2938","article-title":"Carnitine palmitoyltransferase deficiencies","volume":"68","author":"Bonnefont","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.07.018_bb0025","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/ajmg.a.32545","article-title":"Carnitine-palmitoyltransferase 2 deficiency: novel mutations and relevance of newborn screening","volume":"146","author":"Illsinger","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cca.2013.07.018_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.cca.2013.07.018_bb0035","series-title":"GeneReviews\u2122 [Internet]","article-title":"Carnitine palmitoyltransferase II deficiency","author":"Wieser","year":"1993"},{"key":"10.1016\/j.cca.2013.07.018_bb0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.cca.2013.07.018_bb0045","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1096\/fj.12-216689","article-title":"Carnitine palmitoyltransferase 2 and carnitine\/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines","volume":"27","author":"Violante","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2013.07.018_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mus.23498","article-title":"Novel mutations in the gene encoding very long-chain acyl-CoA dehydrogenase identified in patients with partial carnitine palmitoyltransferase II deficiency","volume":"47","author":"Isackson","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cca.2013.07.018_bb0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/jhg.2011.63","article-title":"Fatal viral infection-associated encephalopathy in two Chinese boys: a genetically determined risk factor of thermolabile carnitine palmitoyltransferase II variants","volume":"56","author":"Mak","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cca.2013.07.018_bb0060","doi-asserted-by":"crossref","first-page":"163173","DOI":"10.1155\/2012\/163173","article-title":"Fenofibrate therapy in carnitine palmitoyl transferase type 2 deficiency","volume":"2012","author":"Hamilton-Craig","year":"2012","journal-title":"Case Rep Med"},{"key":"10.1016\/j.cca.2013.07.018_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2012.07.004","article-title":"Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay","volume":"107","author":"Yamaguchi","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.07.018_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.2010.55","article-title":"Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency","volume":"88","author":"Bonnefont","year":"2010","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T05:53:58Z","timestamp":1563602038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113002866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":14,"alternative-id":["S0009898113002866"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.07.018","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel mutations in myopathic form of carnitine palmitoyltransferase II deficiency in a Chinese patient","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}